胃と腸51巻5号

2016年05月発行

増刊号 消化管拡大内視鏡診断2016 主題 大腸

炎症性腸疾患の拡大内視鏡診断─炎症

著者： 野村好紀¹ 藤谷幹浩¹ 岩間琢哉¹ 佐藤裕基¹ 本田宗也¹ 内海辰哉¹ 井尻学見¹ 田中一之¹ 坂谷慧¹ 藤林周吾¹ 上野伸展¹ 嘉島伸¹ 後藤拓麿¹ 笹島順平¹ 盛一健太郎¹

所属機関： ¹旭川医科大学内科学講座消化器・血液腫瘍制御内科学分野

ページ範囲：P.683 - P.689

要旨●炎症性腸疾患における内視鏡検査は疾患の診断や鑑別のみならず，治療効果や経過の評価，治療方針の変更や継続，中止などの判断に重要な検査である．また，粘膜表層の微細構造を観察することのできる拡大内視鏡検査は，粘膜および粘膜下層を主体とした潰瘍性大腸炎の炎症の評価において，特に有用な手技であり，組織学的活動性，治癒過程の推移，再燃の予測が可能となる．潰瘍性大腸炎の拡大内視鏡所見を理解することで，粘膜治癒の評価を適切に行うことができ，症例ごとに最適な治療選択が可能となり，長期の寛解維持へとつながることが期待される．

参考文献

1）Truelove SC, Richards WC. Biopsy studies in ulcerative colitis. Br Med J 1：1315-1318, 1956

2）Matts SG. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 30：393-407, 1961

3）Dick AP, Holt LP, Dalton ER. Persistence of mucosal abnormality in ulcerative colitis. Gut 7：355-360, 1966

4）Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353：2462-2476, 2005

5）Ogata H, Kato J, Hirai F, et al. Double-blind, placebo-controlled trial of oral tacrolimus（FK506）in the management of hospitalized patients with steroid-refractory ulcerative colitis. Inflamm Bowel Dis 18：803-808, 2012

6）Ikeya K, Sugimoto K, Kawasaki S, et al. Tacrolimus for remission induction in ulcerative colitis：Mayo endoscopic subscore 0 and 1 predict long-term prognosis. Dig Liver Dis 47：365-371, 2015

7）Baron JH, Connell AM, Lennard-Jones JE. Variation between Observers in Describing Mucosal Appearances in Proctocolitis. Br Med J 1：89-92, 1964

8）Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317：1625-1629, 1987

9）Rachmilewitz D. Coated mesalazine（5-aminosalicylic acid）versus sulphasalazine in the treatment of active ulcerative colitis：a randomized trial. BMJ 298：82-86, 1989

10）Travis SP, Schnell D, Krzeski P, et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis：the Ulcerative Colitis Endoscopic Index of Severity（UCEIS）. Gut 61：535-542, 2012

11）Samuel S, Bruining DH, Loftus EV Jr, et al. Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. Clin Gastroenterol Hepatol 11：49-54, 2013

12）Nishizawa M, Kariya A, Kobayashi S, et al. Clinical application of an improved magnifying fiber-colonoscope（FCS-ML II）, with special reference to the remission features of ulcerative colitis. Endoscopy 12：76-80, 1980

13）Matsumoto T, Kuroki F, Mizuno M, et al. Application of magnifying chromoscopy for the assessment of severity in patients with mild to moderate ulcerative colitis. Gastrointest Endosc 46：400-405, 1997

14）Tada M, Misaki F, Shimono M, et al. Endoscopic studies on the minute structures of colonic mucosa in the follow-up observation of ulcerative colitis. Gastroenterol Jpn 13：72-76, 1978

15）Fujiya M, Saitoh Y, Nomura M, et al. Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis. Gastrointest Endosc 56：535-542, 2002

16）Kunihiro M, Tanaka S, Sumii M, et al. Magnifying colonoscopic features of ulcerative colitis reflect histologic inflammation. Inflamm Bowel Dis 10：737-744, 2004

17）Nishio Y, Ando T, Maeda O, et al. Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis. Gut 55：1768-1773, 2006

18）Naganuma M, Hosoe N, Kanai T, et al. Recent trends in diagnostic techniques for inflammatory bowel disease. Korean J Intern Med 30：271-278, 2015